Hong Kong Beverage Stock News

Sisram Medical stock has been under pressure, down about 27% over the past three months, yet today’s H1 2026 earnings story is not just about the share price slide. The headline is a clear profit squeeze. Revenue edged up to US$171.4m, but adjusted net profit was only US$5.04m, and the net result swung to a small loss. For a medical aesthetics equipment and injectables business that trades on a P/E of 11.1x and pays a 4.46% dividend, the real question now is how much short term margin pain...

Sun Hung Kai (SEHK:86) drew fresh investor attention on 19 August 2026 after reporting interim results that included HK$688 million in attributable profit, a higher interim dividend of HK$0.13 per share, and ongoing share repurchases. See our latest analysis for Sun Hung Kai. The latest interim results and dividend increase appear to have supported sentiment, with Sun Hung Kai’s share price showing a 3% 1 day return and a 4.3% 7 day return. The 3 year total shareholder return of 89.94% and 5...

Nanshan Aluminium International Holdings stock closed at HK$26.62, roughly flat over the past month but down about 19% over the past quarter. The market has already voted on the story. The earnings tell a tougher version. First half 2026 basic earnings per share of US$0.10 sit well below the trailing twelve month figure of US$0.37, and net profit margins over that trailing period are 23.2% compared with 45.2% a year earlier. In the short term, this is a margin compression story. Over a longer...

Tysan Holdings went into this earnings print with the stock at HK$0.34 and a headline 14.71% dividend yield that already implied investor unease about how secure the payout really is. The half year numbers did little to relax that concern. Revenue for H1 2026 came in at HK$1,150.747m while basic EPS landed at HK$0.0057, leaving trailing net profit margin at 2.2%. The headline this time is pressure on profitability in a construction business that still trades on a 24.7x P/E and carries a...

Nanyang Holdings walked into this earnings season with a tough label. The stock was priced on a rich 3.8x P/S against a weaker real estate industry and carried a history of growing losses and an uncovered dividend. Yet the H1 2026 headline flips that script. The company posted Basic EPS of HK$2.02 and net income of HK$68.7 million, a sharp contrast to the recent loss making record. With the shares closing at HK$29.0 on 20 August, the key question for investors now is whether this profit...

Archosaur Games stock goes into this earnings story on the back foot. The shares closed at HK$1.91, with the price down roughly 2% over the past week and about 16% over three months. Short term traders are focused on another loss in H1 2026, with basic earnings per share of C¥0.09 in the red. The bigger question for you is what that loss means over several years. Archosaur Games now sits on trailing 12 month sales of about C¥1.28b while still unprofitable. The long term debate is whether that...

Chenqi Technology closed at HK$7.98 on Thursday after a strong run over the past month, yet the latest earnings keep the spotlight squarely on profitability rather than price action. The headline from this half year is simple. Revenue reached ¥4,035.204 million, but the company still reported a net loss of ¥68.49 million and a basic loss per share of ¥0.35. That loss is smaller than in recent periods, which matters for a stock trading on a low sales multiple and no profit. The key...

Crystal International Group stock closed at HK$7.49, capping a strong run over the past month. The market has warmed to the story. The real headline from this set of results is the quiet grind higher in profitability. Net profit margin has reached 8.7%, up from 8.2% a year earlier, with earnings over the past 12 months ahead of the previous year. Short term traders may focus on the recent share price jump. Long term holders are more likely to focus on whether this margin trend and the 11.6x...

Hangzhou Jiuyuan Genetic Biopharmaceutical stock has been under pressure, down about 21% over the past three months and 15% over the past month, even before investors could react to this week’s H1 2026 report. The headline is that profits keep grinding higher while the valuation has sunk. Earnings over the past twelve months reached ¥139.5 million with basic earnings per share of ¥0.57. At a trailing P/E of 7.6x against far richer biotech peer multiples, the focus now is on the duration of...

China BlueChemical stock closed at HK$1.995 on Thursday, rounding off a weak few months with the share price down about 19% over 90 days. The market clearly came in cautious. The headline from H1 2026 is that earnings held up better than that mood suggests, with basic earnings per share of ¥0.11 and net income of ¥507.4m on revenue of ¥5.6b. In the short term, the story is about a fertiliser and chemicals producer under share price pressure. Over the longer run, the more important question is...

Kuaishou Technology stock closed at HK$33.64 on Thursday, capping a tough run with the share price down about 26% over the past three months. Yet the latest earnings headline is not about collapse. It is about a deliberate profit squeeze as Kuaishou pours money into artificial intelligence. Second quarter revenue came in at RMB 35.5b with group net profit of RMB 3.1b, while research and development spending jumped to RMB 4.6b. The trade off is clear: short term margins are under pressure. The...

Hong Kong Exchanges and Clearing stock closed at HK$417.8 after a steady run in recent weeks, yet today’s move barely hints at how strong this earnings print looks on a multi year view. The headline is simple: HKEX just delivered record first half revenue of HK$16.7b and profit after tax of HK$10.6b, with earnings per share at HK$8.36. For a market operator built on trading velocity rather than hardware or factories, those records matter. They come at a time when the stock already trades on a...

361 Degrees International came into this week looking like a value play that many investors were still ignoring. The stock closed today at HK$4.83, only modestly higher over the past month, even though the latest half year showed Basic EPS of ¥0.4441 and net income of ¥925.9m. For a sportswear company that often trades on brand heat rather than reported profit, this earnings print put cold, hard profitability back at the centre of the story. Impressed by 361 Degrees International turning in...

Kingsoft stock closed at HK$24.04 on Thursday, with short term returns under pressure after a weak week and month for shareholders. Yet the latest earnings headline is less about the share price wobble and more about what is driving reported profit. The key story this quarter is margin strength flattered by a one off gain of about CN¥1.1b. That lifted trailing net profit margin to 28.4% and helped earnings growth figures look unusually strong. For investors thinking beyond this quarter, the...

Sino Biopharmaceutical stock has been grinding higher in recent weeks, yet today’s reaction hangs almost entirely on one thing. The market is trying to make sense of a solid swing back to profit in H1 2026 while margin pressure refuses to ease. Basic earnings per share of C¥0.19 and net income of C¥3,434.60m mark a sharp contrast to the loss reported in H2 2025. At the same time, the latest net profit margin of 7.1% sits well below last year’s 12.8%. The question for you is whether today’s...

Smoore International Holdings closed at HK$9.86 on Thursday after a solid run over the past week and month. The more significant details, however, lie in the latest earnings. H1 2026 revenue reached ¥7,208.88m with net income of ¥571.92m, and the trailing P/E multiple of 45.8x keeps this stock priced more as a growth story than a value play. The key tension for investors now is the strain between that P/E and a dividend yield of 4.06% that is not well covered by earnings or free cash flow...

Champion Real Estate Investment Trust entered this earnings day with a muted share price record. The stock is roughly flat over one month and has slipped over three months, which suggests investors were cautious rather than excited. The report itself is focused on one key point. Profitability returned to positive territory in the first half of 2026, with basic earnings per unit of HK$0.09 and distributable income of HK$432m, even as rental income and distributions softened. The key question...

Yixin Group entered these H1 results with a stock that had slipped 12.3% over the past month yet held roughly flat over the past quarter. That suggests investors were cautious but not capitulating. The new information is clear: earnings power and margins remain the headline. Adjusted net profit reached about RMB 851m with basic earnings per share at RMB 0.104 and net profit margin for the trailing year at 14.8%. The key question for you now is whether that profitability trend justifies...

Hong Kong Ferry (Holdings) went into this earnings release with the stock roughly flat over the month and down over the past quarter, even as its trailing P/E sat well below both the Hong Kong real estate industry and peer averages. The headline this time is margin power. Over the last 12 months the company delivered a high net profit margin alongside a healthy dividend yield, which together present a picture that appears more profitable than the recent share price drift suggests. Is Hong...

SITC International Holdings stock has been on a strong run into these results, with the past month alone delivering a double digit gain. Yet the real story sits in the earnings power that produced that confidence. The market is trying to price a shipping giant that still converts revenue into profit at a high rate, even as trailing net margin of 35.4% sits below the prior year. With earnings expected to decline over the coming years and the shares already trading at a premium P/E to peers,...

Lepu Biopharma came into today on the back foot, with the stock down about 10% over the past month, and investors clearly questioning whether the earlier move into profitability can hold. The latest half year report now forces a sentiment reset. Revenue for H1 2026 reached C¥522.4m, yet net income from core operations was only C¥27.4m, a sharp contrast with the recent trailing figures that were lifted by a C¥290.4m one off gain. The market reaction looks less like cool analysis and more like...

ZJLD Group walked into this reporting day priced for perfection, trading on a rich 41.5x trailing P/E and slightly above a discounted cash flow reference of HK$4.98 with the stock at HK$7.79. The immediate question is whether the earnings justify that kind of premium or expose a valuation strain. H1 2026 earnings landed with basic earnings per share of ¥0.176 on revenue of ¥2,546.1m while trailing net profit margin sits at 14.7% compared with 21.1% a year earlier. That mix of premium...

Qyuns Therapeutics came into this earnings print with a profitable twelve month track record and a stock that has drifted, with the share price down about 6.6% over the past week but still modestly higher over three months. The headline this half is simple: the company delivered H1 2026 revenue of C¥424.1m and net income of C¥203.3m, which keeps the recent profitability story intact. The tension for you as an investor sits between those solid trailing numbers and a stock valued at roughly...

The market had already cooled on United Company RUSAL International, with the stock down about 23% over the past three months and closing at HK$3.075 today. The latest half year numbers keep the focus squarely on profitability. RUSAL remains loss making on a trailing basis, and earnings still do not cover interest costs. This leaves the income statement under clear strain despite a low 0.4x price to sales multiple versus peers. For investors, this earnings season is less about growth stories...